Okome Nkoumou M M L, Okome Essima R, Obiang Ndong G P, Okome Miame F
Service d'infectiologie, Fondation Jeanne Ebori, BP 212, Libreville, Gabon.
Med Trop (Mars). 2007 Aug;67(4):357-62.
The purpose of this study was to evaluate management of HIV-infected/AIDS patients within the framework of the ACCESS program at Center N 3 over a 4-year period. This retrospective single-center study included HIV-positive patients treated at the Jeanne Ebori Foundation in Libreville, Gabon between January 2002 and December 2005. The active file included 749 patients, i.e., 436 undergoing antiretroviral therapy and 313 with intention to treat. The population consisted mainly of city dwellers. Mean patient age was 38.8 years with a female predominance (sex ratio, 0.8). The highest incidence of infection was observed in the 20- to 30-year age group. Socioeconomic position was low in 63.2 % of patients. Clinical suspicion (67%) was the main reason for testing. In order of frequency, symptoms defined according to the WHO criteria were classified as stage B (33.5 %) and stage C (27.1%). Opportunistic infections were observed in 95% of cases: fungal: 57%, bacterial: 30.7%, and viral: 7.3%. Tritherapy, i.e., 2INTI + 1INNTI (72.9%) and 2INTI+1 IP (17.1%), was used in most cases. Treatment led to clinical improvement with a gradual, steady, and sustained increase in CD4 lymphocyte count. Adverse events were noted including gastrointestinal reactions (16%), neurological manifestations (12%), and general symptoms (12%). Concurrent disturbances in lipid levels and liver function were noted. Overall outcome was positive with a decrease in mortality from 39.2% (M0-M6) to 2.7% (M30-M36). The findings of this study show that improvement in socioeconomic conditions and availability of adequate diagnostic and therapeutic resources at management centers to obtain long-term control of HIV infection are still current issues.
本研究的目的是评估在4年期间,第3中心的ACCESS项目框架内对HIV感染/AIDS患者的管理情况。这项回顾性单中心研究纳入了2002年1月至2005年12月期间在加蓬利伯维尔的珍妮·埃博里基金会接受治疗的HIV阳性患者。有效档案包括749名患者,即436名正在接受抗逆转录病毒治疗的患者和313名有治疗意向的患者。研究人群主要为城市居民。患者平均年龄为38.8岁,女性占主导(性别比为0.8)。20至30岁年龄组的感染发生率最高。63.2%的患者社会经济地位较低。临床怀疑(67%)是检测的主要原因。按照频率排序,根据世界卫生组织标准定义的症状被分类为B期(33.5%)和C期(27.1%)。95%的病例观察到机会性感染:真菌性:57%,细菌性:30.7%,病毒性:7.3%。大多数情况下使用三联疗法,即2种核苷类逆转录酶抑制剂 + 1种非核苷类逆转录酶抑制剂(72.9%)和2种核苷类逆转录酶抑制剂 + 1种蛋白酶抑制剂(17.1%)。治疗使临床症状改善,CD4淋巴细胞计数逐渐、稳定且持续增加。记录到不良事件,包括胃肠道反应(16%)、神经学表现(12%)和全身症状(12%)。同时注意到血脂水平和肝功能的紊乱。总体结果是积极的,死亡率从39.2%(M0 - M6)降至2.7%(M30 - M36)。本研究结果表明,改善社会经济状况以及在管理中心提供充足的诊断和治疗资源以实现对HIV感染的长期控制,仍然是当前面临的问题。